ArticlePloS one2010

FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.

Lucie C Kompier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.